皮罗纳里丁四酸盐是一种有效的抗病毒和抗炎药物,对多种高度致病性冠状病毒具有活性
Jeremy Ardanuy1, Robert Johnson1, Carly Dillen1
1Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine , Baltimore, Maryland, USA.
mBio
|August 15, 2023
概括
在小鼠模型中,四酸皮诺里丁显示出对SARS-CoV-2,SARS-CoV-1和MERS-CoV的显著抗病毒活性. 它还提高了现有的COVID-19治疗方法的疗效,提供了一个有前途的治疗选择.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮罗纳里丁四酸盐是世卫组织必需药物清单中的抗疟疾药物.
- 冠状病毒,包括SARS-CoV-2,SARS-CoV-1和MERS-CoV,对全球健康构成重大威胁.
- 现有治疗严重急性呼吸系统综合征冠状病毒-2 (SARS-CoV-2) 的方法可以得到改进.
研究的目的:
- 评估pyronaridine tetraphosphate对多种冠状病毒的抗病毒疗效.
- 评估pyronaridine与现有的COVID-19治疗的联合治疗.
主要方法:
- 在感染SARS-CoV-2,SARS-CoV-1,和MERS-CoV.病毒的小鼠模型中测试pyronaridine的疗效.
- 评估pyronaridine与nirmatrelvir和molnupiravir联合对抗SARS-CoV-2的添加作用.
主要成果:
- 皮罗纳里丁在各种小鼠模型和冠状病毒变异中表现出高的抗病毒功效.
- 当与尼尔马特里尔维尔和莫尔努皮拉维尔结合时,皮罗纳里丁表现出添加剂效应,增强了SARS-CoV-2的抑制.
- 该化合物在多种动物模型中被证明是有效的,与许多其他抗病毒剂不同.
结论:
- 皮罗纳里丁是一种强大的抗病毒剂,可以对抗多种致病性冠状病毒.
- 皮罗纳里丁代表了管理当前和未来的冠状病毒爆发的有希望的治疗候选者.
- 与pyronaridine的联合治疗可能会提供对SARS-CoV-2的增强保护.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
215
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
215
Subviral Agents
41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41
Cholinergic Antagonists: Therapeutic Uses
776
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
776


